Mycophenolate Mofetil For Oral Suspension IP

उत्पाद वर्णन

MOFECON ORAL SUSPENSION belongs to a group of medicines called immunosuppressants. It is used with other medicines to prevent your body from rejecting an organ (such as a kidney, heart, or liver) after a transplant. It works by weakening your body's immune system, so it does not attack the transplanted organ.

1. What is Mycophenolate Mofetil For Oral Suspension IP?

   • Mycophenolate mofetil for oral suspension is a formulation of the medication mycophenolate mofetil that is prepared as a liquid for oral administration. It contains the active ingredient mycophenolate mofetil, which is an immunosuppressive agent that helps prevent rejection of transplanted organs.

2. How does Mycophenolate Mofetil work?

   • Mycophenolate mofetil works by inhibiting the proliferation of certain types of immune cells, particularly T and B lymphocytes, which are involved in the rejection of transplanted organs. By suppressing the immune system's response, it helps prevent rejection and allows the transplanted organ to function properly.

3. What types of transplants is Mycophenolate Mofetil used for?

   • Mycophenolate mofetil is used in combination with other immunosuppressive medications to prevent rejection in people who have received kidney, heart, or liver transplants. It is often part of a regimen that includes other medications such as corticosteroids and calcineurin inhibitors.

4. How is Mycophenolate Mofetil For Oral Suspension taken?

   • Mycophenolate mofetil for oral suspension is usually taken by mouth, typically twice daily. The dosage and frequency will depend on factors such as the type of transplant, your body weight, and your kidney function. It's important to follow your doctor's instructions carefully and not to adjust your dose without consulting them.

5. What are the possible side effects of Mycophenolate Mofetil?

   • Common side effects of Mycophenolate Mofetil may include diarrhea, nausea, vomiting, abdominal pain, headache, and dizziness. अधिक serious side effects can occur, including bone marrow suppression, which can lead to a decreased number of blood cells and an increased risk of infection or bleeding. It's crucial to report any unusual symptoms to your doctor.

6. Can Mycophenolate Mofetil For Oral Suspension be used during pregnancy or breastfeeding?

   • Mycophenolate mofetil is not recommended for use during pregnancy as it may harm the unborn baby. It should also not be used while breastfeeding as it may pass into breast milk and harm the nursing infant. Women of childbearing age should use effective contraception during treatment and for a period of time after discontinuing the medication.

7. How should Mycophenolate Mofetil For Oral Suspension be stored?

   • Mycophenolate mofetil for oral suspension should be stored at room temperature away from light and moisture. Keep the medication out of reach of children and pets. Do not freeze. Check the expiration date and properly dispose of any expired medication.
   • 
     

 

Premium Immunosuppressant Protection

Mycophenolate Mofetil Suspension IP helps minimize the risk of organ rejection in transplant patients. Formulated specifically for oral administration, it ensures consistent absorption and efficacy to support optimal transplant outcomes. This reconstitutable suspension is versatile for pediatric and adult use as directed by healthcare professionals.


Easy Reconstitution and Administration

The product is packaged as a powder for oral suspension that reconstitutes simply by adding distilled water and shaking well. Supplied with a measuring device, it supports accurate dosing. This user-friendly formulation makes it suitable for both hospital and home settings, as overseen by a physician.


Safe Storage, Reliable Supply

Supplied in a durable HDPE bottle to maintain product stability, Mycophenolate Mofetil Suspension IP should be stored below 25C and protected from moisture and light. With a shelf life of up to two years, the suspension is a dependable option for healthcare providers, distributors, and patients.